These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16188852)

  • 1. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
    Bernstrand C; Sandstedt B; Ahström L; Henter JI
    Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
    Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
    J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
    Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
    Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
    Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
    Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
    Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
    Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis.
    Monsereenusorn C; Suwannaying K; Buaboonnam J; Sathitsamitphong L; Techavichit P; Pakakasama S; Chainansamit SO; Anurathapan U; Komvilaisak P; Traivaree C; Sanpakit K; Charoenkwan P; Seksarn P
    Asian Pac J Cancer Prev; 2024 May; 25(5):1831-1839. PubMed ID: 38809656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
    Martin A; Macmillan S; Murphy D; Carachi R
    Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
    Rigaud C; Barkaoui MA; Thomas C; Bertrand Y; Lambilliotte A; Miron J; Aladjidi N; Plat G; Jeziorski E; Galambrun C; Mansuy L; Lutz P; Deville A; Armari-Alla C; Reguerre Y; Fraitag S; Coulomb A; Gandemer V; Leboulanger N; Moshous D; Hoang-Xuan K; Tazi A; Heritier S; Emile JF; Donadieu J
    Br J Haematol; 2016 Sep; 174(6):887-98. PubMed ID: 27273725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
    Wu FF; Gao YJ; Pan C; Chen J; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis: 40 years' experience.
    Maria Postini A; del Prever AB; Pagano M; Rivetti E; Berger M; Asaftei SD; Barat V; Andreacchio A; Fagioli F
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):353-8. PubMed ID: 22627580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
    Barkaoui MA; Queheille E; Aladjidi N; Plat G; Jeziorski E; Moshous D; Lambilliotte A; Kebaili K; Pacquement H; Leverger G; Mansuy L; Entz-Werlé N; Bodet D; Schneider P; Pagnier A; Lutun A; Gillibert-Yvert M; Millot F; Toutain F; Reguerre Y; Thomas C; Tazi A; Emile JF; Donadieu J; Héritier S
    Br J Haematol; 2020 Dec; 191(5):825-834. PubMed ID: 32700439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis in neonates.
    Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
    Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
    Sedky MS; Rahman HA; Moussa E; Taha H; Raafat T; Hassanein O
    Indian J Pediatr; 2016 Mar; 83(3):214-9. PubMed ID: 26133729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
    Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre.
    Maia RC; de Rezende LM; Robaina M; Apa A; Klumb CE
    Hematology; 2015 Mar; 20(2):83-92. PubMed ID: 24875166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
    Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
    Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
    Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.